SeraCare Life Sciences Announces Decision to Explore Strategic Alternatives; Includes Possible Sale of the Company

SeraCare Life Sciences, Inc.

today announced that its Board of Directors has initiated a process to explore and evaluate potential strategic alternatives for the Company to enhance shareholder value, which may include a sale or other transaction. As previously announced, Lazard is providing advisory services to the Board of Directors.